企業プロフィール
Opko 株価・ニュース・カタリスト
上場廃止
- ティッカー:
- OPKO
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for OPKO.
企業概要
事業概要
Opko is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Opko is followed within the biotech universe for its exposure to catalyst-driven execution.
ビジネスモデルの特徴
Opko follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
バイオ業界での位置付け
Compared with more mature healthcare peers, Opko sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
今後のカタリスト
- OPKO's near-term narrative is still split between diagnostics and the clinical pipeline, but the update feels more specific than usual. MDX2301 and the completed Epstein-Barr vaccine trial are the two pieces that can make the next stretch feel tangible, especially if they keep advancing without needing a reset in direction.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。